Evidence map›Paper›PMID 33595881›Full record

ReviewCellular microbiology2021

Advanced microscopy technologies enable rapid response to SARS-CoV-2 pandemic.

Mirko Cortese, Vibor Laketa

Open access · hybridAbstract readReview
In one paragraph

Review in Cellular microbiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Studying SARS-CoV-2 with Fluorescence Microscopy.International journal of molecular sciences · 2021
    Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Mirko CorteseDepartment of Infectious Diseases, Molecular Virology, University Hospital Heidelberg, Heidelberg, Germany.
Vibor LaketaDepartment of Infectious Diseases, Virology, University Hospital Heidelberg, Heidelberg, Germany.ORCID 0000-0002-9472-2738
Heidelberg University · DE

Funding

Deutsches Zentrum für Infektionsforschung TTU 04.705
6 · The paper itself

Abstract

The ongoing SARS-CoV-2 pandemic with over 80 million infections and more than a million deaths worldwide represents the worst global health crisis of the 21th century. Beyond the health crisis, the disruptions caused by the COVID-19 pandemic have serious global socio-economic consequences. It has also placed a significant pressure on the scientific community to understand the virus and its pathophysiology and rapidly provide anti-viral treatments and procedures in order to help the society and stop the virus spread. Here, we outline how advanced microscopy technologies such as high-throughput microscopy and electron microscopy played a major role in rapid response against SARS-CoV-2. General applicability of developed microscopy technologies makes them uniquely positioned to act as the first line of defence against any emerging infection in the future.

Indexed as

COVID-19COVID-19 Drug TreatmentSARS-CoV-2Antibodies, ViralAntiviral AgentsCOVID-19 Serological TestingCOVID-19 VaccinesCryoelectron MicroscopyDrug DevelopmentHigh-Throughput Screening AssaysHumansMicroscopyMicroscopy, ElectronPandemicsVirus ReplicationAntibodies, ViralAntiviral AgentsCOVID-19 Vaccines

Identifiers

PMID33595881
PMCPMC7995000
OpenAlexW3131217869

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.